HCL Technologies has announced results for Q4 and full FY22, for the period ending March 31, 2022.

Q4 FY21:

• Revenues were $2,993.1m, up 11.0% y/y, up 13.3% in CC
• Operating income (EBIT) was $536.9m, a margin of 17.9%, down 243bps y/y.

Full FY20:

• Revenues were $11,481m, up 12.8%, up 12.7% in CC
• EBIT was $2,170m, a margin of 18.9%, down 246 bps.

Q4 FY22 revenue share by service line (with revenues and y/y growth in US$) is:

• IT and Business Services 73.5% ($2,199m; +13.5%) +16.2% in CC
• Engineering and R&D services 16.4% ($490m, +20.1%) +23.7% in CC.
• Products & Platforms 10.2% ($304m; -13.1%) -13.9% in CC

Q4 FY22 revenue share by region (with NelsonHall estimates of revenue) is:

• Americas 62.8% ($1,880m) +13.0% in CC 
• Europe 28.3% ($847m), +10.1%  in CC
• RoW 8.9% ($266m), +18.7% in CC

Q4 FY22 revenue share by sector (with estimated revenue) is:

• Financial Services 20.9% ($626m) +10.2% in CC 
• Manufacturing 18.0% ($539m) +16.6% in CC 
• Technology & Services 17.5% ($524m) +14.3% in CC 
• Retail & CPG 9.4% ($281m) +6.0% in CC 
• Telecom, Media, Publishing & Entertainment 8.6% ($257m) +20.2% in CC 
• Life Sciences & Healthcare 14.9% ($446m) +18.5% in CC 
• Public sector 10.7% ($320m) +7.8%. in CC 

FY22 revenue share by service line (with revenues and y/y growth in US$) is:

• IT and Business Services 72.1% ($8,276m; +14.8%) +14.5% in CC
• Engineering and R&D services 15.8% ($1,818m, +14.7%) +16.8% in CC.
• Products & Platforms 12.1% ($1,387m; +8.2%) -1.3% in CC

FY22 revenue share by region (with NelsonHall estimates of revenue) is:

• Americas 62.9% ($7,221m) +13.0% in CC 
• Europe 28.2% ($3,238m), +10.1%  in CC
• RoW 8.9% ($1,022m), +18.7% in CC

FY22 revenue share by sector (with estimated revenue and y/y growth) is:

• Financial Services 21.3% ($2,445m) +9.2% in CC 
• Manufacturing 17.7% ($2,032m) +10.8% in CC 
• Technology & Services 17.6% ($2,021m) +14.4% in CC 
• Retail & CPG 9.8% ($1,125m) +8.9% in CC 
• Telecom, Media, Publishing & Entertainment 8.1% ($930m) +15.7% in CC 
• Life Sciences & Healthcare 14.8% ($1,699m) +20.6% in CC 
• Public sector 10.6% ($1,217m) +10.4%. in CC 

LTM key client contribution to revenue (and at end Q3 FY22) was:

• Top 5: 11.5% (12.2%)
• Top 10: 19.8% (20.3 %)
• Top 20: 29.1% (29.4% ).

HCL signed 10 transformational deals in Q4 led by the g technology and services, life sciences and healthcare and public services verticals.

HCL signed  52 transformational deals in 2020 led by life sciences and healthcare, technology, financial services, manufacturing and oil & gas.

Total headcount at end March 2022 was 208,877, a net increase of 39,900 during the quarter, and a growth of 23.6% y/y. 

LTM attrition in IT services was 21.9%, up from 12.3% in Q4 FY21.